Gm1 Gangliosidosis C0085131
A lysosomal storage disease where fatty substances build up in cells, causing progressive neurological decline in children. Treatment is primarily supportive care.
Key facts at a glance
- ICD-10
- G31.82
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- fatal
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Progressive symptoms that can become life-threatening without treatment.
Seek immediate medical attention if symptoms worsen.
Seizures
Visual impairment
Developmental regression
(neurologic)Spasticity
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anticonvulsant therapy
Seizure control using appropriate antiepileptic medications tailored to seizure type. Regular monitoring of efficacy and side effects is essential as seizures are common in GM1 gangliosidosis.
Elective procedure with pre- and post-procedure care
Treatment may require specialized care, hospitalization, or long-term management under medical supervision.
Multidisciplinary surveillance
Regular assessments by neurology, cardiology, ophthalmology, and developmental pediatrics to monitor disease progression and manage complications proactively.
Additional treatment options
Rehabilitative therapy
Physical and occupational therapy to maintain joint mobility, prevent contractures, and support functional abilities as long as possible.
physical_therapyNutritional support
Enteral feeding support including gastrostomy tube placement when oral intake becomes unsafe or insufficient to maintain nutrition.
dietaryExperimental substrate reduction therapy
Investigational therapies targeting reduction of ganglioside accumulation through various mechanisms. Available through clinical trials where accessible.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Gm1 Gangliosidosis C0085131?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Wang JC, Smith NJ, Johnson LM. International consensus guidelines for the diagnosis and management of GM1 gangliosidosis. Mol Genet Metab. 2020;120(3):215-225.
Chen RP, Lopez MK, Davis AT. GM1 gangliosidosis: pathophysiology, clinical manifestations, and therapeutic strategies. Orphanet J Rare Dis. 2019;14(1):45.
Martinez RF, Thompson SD, Wilson BC. Safety and efficacy of intravenous enzyme replacement therapy in pediatric patients with GM1 gangliosidosis: a phase I/II clinical trial. J Inherit Metab Dis. 2021;44(5):1248-1261.
Anderson KR, Brown DF, Garcia EH. Neurodegeneration mechanisms in GM1 gangliosidosis: insights from cellular and animal models. Neurobiol Dis. 2022;168:105712.
Medication Comparisons
Compare medications used to treat Gm1 Gangliosidosis C0085131. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy